Acute Myeloid Leukemia of Donor Origin After Allogeneic Bone Marrow Transplantation for Precursor T-Cell Acute Lymphoblastic Leukemia: Case Report and Review of the Literature

TitleAcute Myeloid Leukemia of Donor Origin After Allogeneic Bone Marrow Transplantation for Precursor T-Cell Acute Lymphoblastic Leukemia: Case Report and Review of the Literature
Publication TypeJournal Article
Year of Publication2006
AuthorsReichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K
Volume81
Issue3
Pagination7
Date PublishedMarch
ISSN0361-8609
Accession Number01445364-200603000-00005
Keywordsallogeneic BMT, bone marrow transplantation., Clinical Medicine., donor leukemia
Abstract

: We report a case of donor-derived acute myeloid leukemia (AML) occurring in a 33-yearold man after allogeneic bone marrow transplantation (BMT) for precursor T-cell acute lymphoblastic -leukemia (T-ALL). The cells for BMT were from his human leukocyte antigen (HLA)-matched sister. Fluorescence in-situ hybridization (FISH) analysis showed the AML to be of donor origin (i.e., karyotypically female) with an 11q23 (mixed lineage leukemia (MLL) gene) translocation, while the original T-ALL exhibited a male karyotype with abnormalities of chromosomes 6, 8, and a t(10;14)(q24;q11.2). Subsequent molecular short tandem repeat studies confirmed the AML to be of donor origin. Donor-cell leukemia (DCL) after allogeneic BMT is a rare, yet well-documented, event. Our report presents clinicopathologic information about a case of DCL and a review of the recent literature. Am. J. Hematol. 81:178-185, 2006. (C) 2006 Wiley-Liss, Inc. Copyright (C) 2006 John Wiley & Sons, Inc.; References: 1. Au WY, Lie AK, Ma SK, et al. Therapy related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukemia. Br J Haematol 2001;112:424-426. 2. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994;84:3603-3612. 3. McCann S, Wright E. Donor leukemia: perhaps a more common occurrence than we thought! (editorial). Bone Marrow Transplant 2003;32:455-457. 4. Fialkow PJ, Thomas ED, Bryant JI, et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971;1: 251-255. 5. Thomas ED, Bryant JI, Buckner CD, et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1972;1:1310-1313. 6. Goh KO, Klemperer MR. In vivo leukemia transformation: cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells. Am J Hematol 1977;2:283-290. 7. Elfenbein GJ, Brogaonkar DS, Bias WB, et al. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood 1978;52:627-635. 8. Newburger PE, Latt SA, Pesando JM, et al. Leukemia relapse in donor cells after allogeneic bone marrow transplantation. New Engl J Med 1981;304:712-714. 9. Marmont A, Frassoni F, Bacigalupo A, et al. Recurrence of Phpositive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. New Engl J Med 1984;310:903-906. 10. McCann SR, Lawler M, Humphries P, et al. Recurrence of Philadelphia chromosome positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: confirmation by microsatellite studies (letter). Blood 1992;79:2803-2805. 11. Smith JL, Heerema NA, Provisor AJ. Leukaemic transformation of engrafted bone marrow cells. Br J Haematol 1985;60:415-422. 12. Witherspoon RP, Schubach W, Neiman P, et al. Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood 1985;65:1172-1174. 13. Zaccaria A, Rosti G, Testoni N, et al. Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation-results of a European cooperative study. Cancer Genet Cytogenet 1987;26: 51-58. 14. Schmitz N, Johanason W, Schmidt G, et al. Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood 1987;70:1099-1104. 15. Feig SA, Dreazen O, Simon M, et al. B-cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T-cell ALL. Bone Marrow Transplant 1988;3:331-337. 16. Browne PV, Lawler M, Humphries PM, et al. Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. New Engl J Med 1991;325:710-713. 17. Cullis JO, Marks DI, Schwarer AP, et al. Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukemia: a report of five cases. Br J Haematol 1992;81: 378-382. 18. Mouratidou M, Sotiropoulos D, Deremitzaki K, et al. Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. Bone Marrow Transplant 1993;12:77-80. 19. Cransac M, Boiron J-M, Merel P, et al. Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation 1993;56:120-123. 20. Katz F, Reeves BR, Alexander S, et al. Leukemia arising in donor cells following allogeneic bone marrow transplantation for thalassemia demonstrated by immunological, DNA and molecular cytogenetic analysis. Br J Haematol 1993;85:326-331. 21. Lowsky R, Fyles G, Minden M, et al. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol 1996;93:163-165. 22. Cooley LD, Sears DA, Udden MM, et al. Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol 2000;63:46-53. 23. Hambach L, Eder M, Dammann E, et al. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 2001;28:705-707. 24. Lawler M, Locasciulli A, Longoni D, et al. Leukaemic transformation of donor cells in a patient receiving a second bone marrow transplant for severe aplastic anaemia. Bone Marrow Transplant 2002;29:453-456. 25. Au WY, Chan EC, Siu LLP, et al. Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol 2002;119:777-780. 26. Gopcsa L, Barta A, Banyai A, et al. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 2002;29:449-452. 27. Brunstein CG, Hirsch BA, Hammerschmidt D, et al. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 2002;29:999-1003. 28. Komeno Y, Kanda Y, Kandabashi K, et al. Reduced-intensity bone marrow transplantation from an alternate unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol 2003;72:220-222. 29. Bielorai B, Deeg HJ, Weintraub M, et al. B-cell lymphoma developing in the donor after donor-origin acute myeloid leukemia post bone marrow transplantation. Bone Marrow Transplant 2003;31:931-934. 30. Haltrich I, Muller J, Szabo J, et al. Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet 2003;142:124-128. 31. Au WY, Lam CCK, Lie AKW, et al. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol 2003;120:626-630. 32. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in threecolor analysis. Am J Clin Pathol 1993;100:534-540. 33. ISCN. An International System for Human Cytogenetic Nomenclature, Mitelman F(ed.), S. Karger, Basel, 1995. 34. Minden MD, Messner HA, Belch A. Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism. J Clin Invest 1985;75:91-93. 35. Ginsburg D, Antin JH, Smith BR, et al. Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms. J Clin Invest 1985;75:596-603. 36. Spinelli O, Giussani U, Borlero G, et al. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica 2000;85:1153-1157. 37. Schuler F, Hirt C, Dolken G. Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol 2003;13(3): 203-209. 38. Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocation in healthy individuals. Genes Chromosomes Cancer 2003;36:211-223. 39. Unken FM, Herman-Hatten K, Crotty M, et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 1998;92:810-821. 40. TrkaJ, Zuna J, Hrusak O, et al. No evidence for MLL/AF4 expression in normal cord blood samples. Blood 1999; 93:1106-1107. 41. Kim-Rouille MH, MacGregor A, Wiedemann LM, et al. MLL-AF4 gene fusions in normal newborns. Blood 1999;93:1107-1108.

DOI10.1002/ajh.20389
Alternate JournalAm.J.Hematol.
Notify Library Reference ID1823

Related Incidents